Macrophage efferocytosis in cardiovascular disease: mechanisms and therapeutic implications

Area of Science:

• Cardiovascular biology
• Immunology
• Cellular homeostasis

Background:

• Cardiovascular diseases (CVDs) cause millions of deaths globally, with inflammation playing a key role in their pathogenesis.
• Dysregulated inflammation accelerates disease progression and disrupts cellular homeostasis, leading to adverse clinical outcomes.
• Efficient resolution of inflammation and restoration of tissue integrity are critical for managing CVDs.

Purpose of the Study:

• To review the current understanding of macrophage efferocytosis in the context of cardiovascular health.
• To explore the molecular mechanisms underlying efferocytosis and its role in resolving cardiac inflammation.
• To highlight the therapeutic potential of enhancing efferocytosis for treating CVDs.

Main Methods:

• This mini-review consolidates existing research on macrophage efferocytosis.
• It examines the molecular mechanisms involved in the clearance of apoptotic cells by cardiac macrophages.
• The review synthesizes findings on the association between efferocytosis efficiency and CVD outcomes.

Main Results:

• Efficient efferocytosis by cardiac macrophages is essential for resolving inflammation and restoring tissue homeostasis.
• Impaired efferocytosis perpetuates inflammation, exacerbates CVD progression, and hinders recovery.
• Successful efferocytosis suppresses pro-inflammatory cytokines and promotes anti-inflammatory responses.

Conclusions:

• Macrophage efferocytosis is an underappreciated yet critical process in cardiovascular health.
• Enhancing efferocytosis presents a promising therapeutic strategy for managing and treating cardiovascular diseases.
• Further research into efferocytosis mechanisms can unlock new avenues for CVD interventions.